Table 5.
Lymphocyte Subsets levels in patients with COVID-19.
| Laboratory finding | Mild disease | Moderate disease | Severe disease | Critically ill | Total | p value |
|---|---|---|---|---|---|---|
| Lymphocyte count, cells/μl | 1767.57 ± 587.82 a.b.c# | 1202.35 ± 483.66 e* | 861.50 ± 464.96 | 746.88 ± 503.44 | 1172.49 ± 560.25 | 0.001 |
| T lymphocyte count, cells/μl | 1210.75 ± 408.81 a.b.c# | 808.97 ± 371.22 d*e# | 522.57 ± 318.73 | 464.67 ± 339.68 | 778.98 ± 417.65 | 0.000 |
| CD4 T lymphocyte count, cells/μl | 689.38 ± 251.29 a.b.c# | 436.8 ± 225.08 d*e# | 257.86 ± 129.48 | 270.11 ± 162.75 | 425.36 ± 242.55 | 0.000 |
| CD8 T lymphocyte count, cells/μl | 462.88 ± 154.43 b.c# | 355.33 ± 166.86 d*e# | 205.14 ± 153.09 | 202.22 ± 199.10 | 330.43 ± 184.26 | 0.004 |
| B lymphocyte count, cells/μl | 330.71 ± 177.65 a.b.c# | 148.92 ± 89.33 | 128.83 ± 42.44 | 119.38 ± 59.07 | 164.71 ± 113.66 | 0.000 |
| NK cell count, cells/μl | 288 ± 175.93 | 203.63 ± 209.433 | 185.00 ± 180.11 | 102.88 ± 72.28 | 196.14 ± 189.03 | 0.310 |
| CD4/CD8 ratio | 1.53 ± 0.41 | 1.62 ± 1.86 | 1.28 ± 0.76 | 2.42 ± 1.56 | 1.63 ± 1.57 | 0.671 |
*p < 0.05.
#p < 0.01.
a
Compared between mild and moderate disease.
b
Compared between mild and severe disease.
c
Compared between mild disease and critically ill.
d
Compared between moderate and severe disease.
e
Compared between moderate disease and critically ill.